CN103012532A - Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate - Google Patents
Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate Download PDFInfo
- Publication number
- CN103012532A CN103012532A CN201210526902XA CN201210526902A CN103012532A CN 103012532 A CN103012532 A CN 103012532A CN 201210526902X A CN201210526902X A CN 201210526902XA CN 201210526902 A CN201210526902 A CN 201210526902A CN 103012532 A CN103012532 A CN 103012532A
- Authority
- CN
- China
- Prior art keywords
- crystallization
- add
- vacuum
- dryings
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960001661 ursodiol Drugs 0.000 title claims abstract description 36
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 title abstract 3
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 claims abstract description 33
- 229960001091 chenodeoxycholic acid Drugs 0.000 claims abstract description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000002425 crystallisation Methods 0.000 claims description 95
- 230000008025 crystallization Effects 0.000 claims description 95
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 72
- 238000001291 vacuum drying Methods 0.000 claims description 49
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 21
- 239000000047 product Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- 241000283690 Bos taurus Species 0.000 claims description 17
- 241001494479 Pecora Species 0.000 claims description 17
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- 239000003613 bile acid Substances 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 14
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 14
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 9
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 9
- 238000010792 warming Methods 0.000 claims description 9
- DLYVTEULDNMQAR-SRNOMOOLSA-N Cholic Acid Methyl Ester Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCC(=O)OC)[C@@]2(C)[C@@H](O)C1 DLYVTEULDNMQAR-SRNOMOOLSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 239000001632 sodium acetate Substances 0.000 claims description 7
- 229960004249 sodium acetate Drugs 0.000 claims description 7
- 235000017281 sodium acetate Nutrition 0.000 claims description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- 235000017550 sodium carbonate Nutrition 0.000 claims description 7
- 239000001117 sulphuric acid Substances 0.000 claims description 7
- 235000011149 sulphuric acid Nutrition 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000003252 repetitive effect Effects 0.000 claims description 2
- 238000005201 scrubbing Methods 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 abstract description 8
- 235000019416 cholic acid Nutrition 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- -1 chenodeoxycholic acid compound Chemical class 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 239000002812 cholic acid derivative Substances 0.000 abstract 1
- 150000001842 cholic acids Chemical class 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 238000006722 reduction reaction Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 7
- 239000004380 Cholic acid Substances 0.000 description 7
- 229960002471 cholic acid Drugs 0.000 description 7
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 7
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 4
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- 206010008635 Cholestasis Diseases 0.000 description 2
- 208000006154 Chronic hepatitis C Diseases 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 208000010710 hepatitis C virus infection Diseases 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UYVVLXVBEQAATF-UHFFFAOYSA-N 4-(1,3,7,12-tetrahydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid Chemical compound OC1CC2CC(O)CC(O)C2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 UYVVLXVBEQAATF-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000018672 Dilatation Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000001493 benign recurrent intrahepatic cholestasis Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000002220 organoid Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210526902XA CN103012532A (en) | 2012-12-10 | 2012-12-10 | Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210526902XA CN103012532A (en) | 2012-12-10 | 2012-12-10 | Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103012532A true CN103012532A (en) | 2013-04-03 |
Family
ID=47961681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210526902XA Pending CN103012532A (en) | 2012-12-10 | 2012-12-10 | Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103012532A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104017043A (en) * | 2014-06-20 | 2014-09-03 | 华东理工大学 | Method for purifying ursodesoxycholic acid by adopting silanization technology |
CN109825547A (en) * | 2019-03-18 | 2019-05-31 | 常德云港生物科技有限公司 | A method of passing through half enzymatic clarification ursodesoxycholic acid by raw material of cholic acid |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139399A (en) * | 1983-01-31 | 1984-08-10 | Showa Denko Kk | Production of ursodeoxycholic acid |
JP2004307390A (en) * | 2003-04-07 | 2004-11-04 | Mitsubishi Chemicals Corp | Method for producing steroid compound |
CN1850846A (en) * | 2006-05-23 | 2006-10-25 | 辽宁百隆生物工程有限公司 | Production method for extracting chenodeoxycholic acid using chicken gall |
CN101215309A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Method for producing chenodeoxycholic acid by using 98% of bovine and ovine cholic acid |
CN101215310A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Production method for producing ursodesoxycholic acid by using 98.0% of bovine and sheep cholic acid |
CN101215311A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Method for producing ursodeoxycholic acid by using 86% chenodeoxycholic acid |
ES2318927A1 (en) * | 2005-08-25 | 2009-05-01 | Universidade De Santiago De Compostela | New dimers of biliary acids functionalized in the position 24 of the biliary salt chain chain. Procedures for your obtaining and applications. (Machine-translation by Google Translate, not legally binding) |
-
2012
- 2012-12-10 CN CN201210526902XA patent/CN103012532A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139399A (en) * | 1983-01-31 | 1984-08-10 | Showa Denko Kk | Production of ursodeoxycholic acid |
JP2004307390A (en) * | 2003-04-07 | 2004-11-04 | Mitsubishi Chemicals Corp | Method for producing steroid compound |
ES2318927A1 (en) * | 2005-08-25 | 2009-05-01 | Universidade De Santiago De Compostela | New dimers of biliary acids functionalized in the position 24 of the biliary salt chain chain. Procedures for your obtaining and applications. (Machine-translation by Google Translate, not legally binding) |
CN1850846A (en) * | 2006-05-23 | 2006-10-25 | 辽宁百隆生物工程有限公司 | Production method for extracting chenodeoxycholic acid using chicken gall |
CN101215309A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Method for producing chenodeoxycholic acid by using 98% of bovine and ovine cholic acid |
CN101215310A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Production method for producing ursodesoxycholic acid by using 98.0% of bovine and sheep cholic acid |
CN101215311A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Method for producing ursodeoxycholic acid by using 86% chenodeoxycholic acid |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104017043A (en) * | 2014-06-20 | 2014-09-03 | 华东理工大学 | Method for purifying ursodesoxycholic acid by adopting silanization technology |
CN109825547A (en) * | 2019-03-18 | 2019-05-31 | 常德云港生物科技有限公司 | A method of passing through half enzymatic clarification ursodesoxycholic acid by raw material of cholic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101215310A (en) | Production method for producing ursodesoxycholic acid by using 98.0% of bovine and sheep cholic acid | |
CN101987860B (en) | Preparation method of ursodesoxycholic acid | |
EP2985275B1 (en) | Beta-hydroxy-beta-methylbutyric acid purification method | |
CN102827234A (en) | Method for separating and purifying chenodeoxycholic acid from duck gall | |
CN101215311B (en) | Method for producing ursodesoxycholic acid from 86% of chenodeoxycholic acid | |
CN110790805B (en) | Method for extracting chenodeoxycholic acid from pig bile paste | |
CN110256517B (en) | Method for producing high-purity chenodeoxycholic acid from pig bile or leftovers | |
CN103724396A (en) | Preparation method of R-budesonide | |
CN103012532A (en) | Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate | |
CN101215309A (en) | Method for producing chenodeoxycholic acid by using 98% of bovine and ovine cholic acid | |
CN102911235A (en) | Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material | |
JP5259624B2 (en) | A purification method comprising dissolving an organic compound in carbonated water and freeze-drying | |
CN103804453B (en) | The method preparing ursodesoxycholic acid for raw material with Fel Sus domestica | |
CN103254265A (en) | Abiraterone acetate trifluoroacetate, and preparation method and application thereof | |
ITMI20061735A1 (en) | PROCEDURE FOR THE PREPARATION OF COLANIC ACIDS | |
CN103992263B (en) | A kind of purification process of E2020 | |
CN104119414A (en) | Preparation method of high-quality progesterone | |
CN105481927A (en) | Method for extracting cholic acid of ducks and chenodeoxycholic acid (CDCA) from bile of ducks | |
CN102964416A (en) | Method for producing chenodeoxycholic acid by using 98.5% sodium cholate | |
EP2545065B1 (en) | Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof | |
CN103012539B (en) | The production method of ursodeoxycholic acid is produced with the ursodesoxycholic acid of content 98.5% | |
CN111732625A (en) | Preparation method of sisalagenin secondary glycoside methylated compound | |
CN111285915A (en) | Novel process for extracting and refining chenodeoxycholic acid from poultry gall bladder | |
JPS6254316B2 (en) | ||
CN105646635B (en) | Cholic acid method is reclaimed from chicken courage extraction industrial wastes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: LIAONING BAILONG BIOENGINEERING CO., LTD. Free format text: FORMER OWNER: LIAONING BAIFENG BIOLOGY PHARMACEUTICAL CO., LTD. Effective date: 20130407 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 117004 BENXI, LIAONING PROVINCE TO: 110122 SHENYANG, LIAONING PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130407 Address after: 110122, No. two, No. 24 South Road, Shitai economic and Technological Development Zone, Shenyang, Liaoning Applicant after: Liaoning Bailong Bioengineering Co., Ltd. Applicant after: Liu Mohan Address before: 117004, Liaoning, Benxi Province, Lake District, stone bridge, spring Ann street, No. 5 Applicant before: LIAONING BAIFENG BIO-PHARMACEUTICAL CO., LTD. Applicant before: Liaoning Bailong Bioengineering Co., Ltd. Applicant before: Liu Mohan |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130403 |